Bullous acral erythema: an additional consideration in the differential diagnosis of pauci-inflammatory subepidermal bullae*

Journal of Cutaneous Pathology
Joshua O Podjasek, Michael J Camilleri

Abstract

Acral erythema is considered a frequent complication of chemotherapy administration. The bullous variant of chemotherapy-induced acral erythema, or bullous acral erythema, occurs less commonly. The condition typically begins with acral dysesthesias and produces symmetric erythema that blisters and eventually desquamates. Overall, 32 cases of bullous acral erythema have been described in the literature, including 21 cases associated with cytarabine administration and 11 cases attributed to methotrexate. We describe a 61-year-old woman with diffuse large B-cell lymphoma in whom bullous acral erythema developed after she received cytarabine and methotrexate. The clinical presentation was unusual, as it was characterized by vesicles in an annular configuration suggestive of linear immunoglobulin A bullous disease. Histopathology revealed a pauci-inflammatory subepidermal bulla that was similar to previously reported cases of bullous acral erythema. We suggest that bullous acral erythema represents an important diagnostic consideration in the differential diagnosis of pauci-inflammatory subepidermal blistering in patients who have recently received chemotherapy.

References

Mar 1, 1991·Journal of the American Academy of Dermatology·B R Baack, W H Burgdorf
Jun 1, 1989·Journal of Cutaneous Pathology·J BhawanM E Rybak
Sep 1, 1986·Archives of Dermatology·M K CriderM S McHale
Apr 1, 1985·Annals of Internal Medicine·M R BaerS N Wolff
Nov 1, 1985·Annals of Internal Medicine·W G Peters, R Willemze
Jul 1, 1982·Annals of Internal Medicine·W H BurgdorfR G Ganick
Nov 1, 1982·Annals of Internal Medicine
Feb 1, 1993·Journal of Cutaneous Pathology·T SerranoA Moreno
Jan 1, 1993·Archives of Dermatology·J F Waltzer, F P Flowers
Sep 1, 1996·Thérapie·J M Bonnetblanc, P Bernard
Aug 1, 1997·International Journal of Dermatology·Z DemirçayM Bayik
May 6, 1999·Acta Dermato-venereologica·E Vargas-DíezA García-Díez
May 8, 1999·Clinical and Experimental Dermatology·R M AzurdiaP S Friedmann
Nov 26, 1999·Pediatric Dermatology·F MillotF Guilhot
Sep 6, 2000·Journal of the European Academy of Dermatology and Venereology : JEADV·E Ozkaya-BayazitY Pekçelen
Sep 30, 2000·Clinical and Experimental Dermatology·D TsurutaK E Takekawa
Jan 5, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·M SokerK Haspolat
May 7, 2002·Journal of Pediatric Hematology/oncology·Dean S MorrellNancy B Esterly
Apr 5, 2005·Pediatric Hematology and Oncology·Sergey Postovsky, Myriam Weyl Ben Arush
Apr 29, 2005·Journal of the American Academy of Dermatology·Andrew E WerchniakJames G H Dinulos
Dec 21, 2006·Indian Journal of Dermatology, Venereology and Leprology·Sheela KuruvilaB Sivanesan
Oct 26, 2007·Pediatric Dermatology·Carly R VarelaRichard J Antaya
May 7, 2008·Journal of Pediatric Hematology/oncology·Hasan TezerGülten Seçmeer
Aug 13, 2008·Journal of the American Academy of Dermatology·Jean L BologniaEarl J Glusac

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of the American Academy of Dermatology
Andrew E WerchniakJames G H Dinulos
Journal of the American Academy of Dermatology
J L BologniaEarl J Glusac
Journal of the American Academy of Dermatology
B R Baack, W H Burgdorf
© 2022 Meta ULC. All rights reserved